Solvophobic Linker Compounds for Medical Device Surface Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The development of medical devices with bioactive agents bound directly to the device for localized treatment is complex, often limited by reaction schemes and by-products upon device degradation in the body.
Innovation Solution
Compounds with solvophilic and solvophobic portions, where the solvophobic portion is functionalized with reactive members, allowing for the simple combination and blending to create an activated medical device capable of attaching bioactive agents without complex cross-linking reactions, using a solvent matrix that positions the reactive members at the device surface.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If complex reaction schemes and cross-linking reactions are used to bind bioactive agents to medical devices, then the binding strength and reliability are improved, but the device complexity and manufacturing difficulty increase
Solution Approach 1:
The compound is divided into distinct functional segments: a solvophilic portion that interacts with the solvent matrix and a solvophobic portion that presents reactive members at the surface. This segmentation allows each portion to perform its specific function independently, simplifying the overall binding process while maintaining reliability
Solution Approach 2:
The solvophobic portion acts as an intermediary between the solvent matrix and bioactive agents. It presents reactive members that can directly interact with bioactive agents without requiring complex cross-linking chemistry, thus simplifying the binding mechanism while ensuring reliable attachment
2Adaptability or versatility
If complex cross-linking reactions are used to activate medical devices, then the reactivity and bioactive agent attachment capability are improved, but the manufacturing simplicity is reduced
Solution Approach 1:
The reactive members are pre-positioned on the solvophobic portion during compound synthesis, before the medical device is activated or used. This preliminary preparation eliminates the need for complex activation procedures later, allowing simple blending with the solvent matrix to create the activated device
Solution Approach 2:
When the compound is blended with the solvent matrix, the solvophobic portion automatically migrates to the surface and self-organizes to present reactive members. This self-service behavior eliminates the need for complex external activation processes, simplifying manufacturing while maintaining high attachment capability
3Quantity of substance
If reactive members are positioned throughout the bulk of the device, then the total number of reactive sites is increased, but the surface reactivity and localized attachment efficiency are reduced
Solution Approach 1:
The solvophobic portion is designed with local quality that causes it to preferentially locate at the device surface when blended with the solvent matrix. This ensures reactive members are concentrated where they are most needed for bioactive agent attachment, improving surface reactivity and localized efficiency
Solution Approach 2:
The reactive members are distributed throughout the bulk in three dimensions during mixing, but the solvophobic portion's amphiphilic nature causes them to self-organize into a two-dimensional surface layer. This dimensional transition concentrates reactive members at the surface without requiring precise positioning during manufacturing
4Adaptability or versatility
If bioactive agents are delivered systemically through intravenous means, then the treatment coverage is improved, but the localization precision to the disease site is reduced
Solution Approach 1:
The invention extracts the bioactive agent delivery from the bloodstream and relocates it to the implant site. By binding agents directly to the medical device, the treatment is localized precisely where the device is implanted, eliminating systemic distribution while maintaining effective treatment coverage at the target site
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the easy attachment of bioactive agents to the medical device surface, simplifying the production process and potentially improving the localized delivery of therapeutic agents while minimizing adverse reactions and by-products during device degradation.
Implementation Method 1
a solvophobic portion that is relatively incompatible with the solvent matrix and therefore remains at or near the surface of the device
Data Source
AI summary
The present disclosure relates to compounds and medical devices activated with a solvophobic material functionalized with a first reactive member and methods of making such compounds and devices.